Background illustration for clinical trials search

Paid Clinical Trials Buffalo

Discover 779 paid clinical trials in Buffalo, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis
Location: Hamilton, Toronto, London, Pittsburgh PA, Westlake OH,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07185009

Phase 3, Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Hamilton, Oakville, Toronto, Brampton, London,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184931

Phase 3, Recruiting

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

for
Heart Failure, Acute Heart Failure
Location: Toronto, North York, Cambridge, London, Pittsburgh PA,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06008197

Phase 3, Recruiting

Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding

for
Acute Gastrointestinal Bleeding
Location: Toronto, Piscataway NJ, New York NY, Manhasset NY,
Sponsor: Medtronic - MITG

Sex: All

Age: 22+

Code: NCT06188585

Recruiting

A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

for
Hidradenitis Suppurativa (HS)
Location: Toronto, The Bronx NY, Montreal, Boston MA,
Sponsor: Navigator Medicines, Inc.

Sex: All

Age: 18 - 70

Code: NCT07384975

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

for
Focal Segmental Glomerulosclerosis,
Location: Toronto, London, Cleveland OH, Ann Arbor MI,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT06500702

Phase 2, Recruiting

A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

for
Chronic Graft Versus Host Disease
Location: Toronto, Washington D.C. DC, New York NY, Boston MA,
Sponsor: Sanofi

Sex: All

Age: 1 - 18

Code: NCT07116031

Phase 2, Recruiting

Product Surveillance Registry

for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Toronto, Erie PA, Kingston, Cleveland OH, Danville PA,
Sponsor: Medtronic

Sex: All

Age: 0+

Code: NCT01524276

Recruiting

Pompe Disease Registry Protocol

for
Glycogen Storage Disease Type II, Pompe Disease
Location: Toronto, London, Syracuse NY, Cleveland OH,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00231400

Recruiting

Fabry Disease Registry & Pregnancy Sub-registry

for
Fabry Disease
Location: Toronto, London, Syracuse NY, Cleveland OH,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00196742

Recruiting

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

for
Gaucher Disease, Cerebroside Lipidosis Syndrome,
Location: Toronto, Rochester NY, London, Syracuse NY,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00358943

Recruiting

A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study

for
Propionic Acidemia
Location: Toronto, Ann Arbor MI, Philadelphia PA, New York NY,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 1+

Code: NCT05130437

Phase 1, Phase 2, Recruiting

Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC

for
Neurogenic Detrusor Overactivity
Location: Toronto, Syracuse NY, Albany NY, Jacksonville FL,
Sponsor: Urovant Sciences GmbH

Sex: All

Age: 2 - 17

Code: NCT05491525

Phase 2, Phase 3, Recruiting

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

for
Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis,
Location: Toronto, London, Greater Sudbury, Glen Burnie MD,
Sponsor: Spyre Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07012395

Phase 2, Recruiting

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors
Location: Toronto, Detroit MI, Fairfax VA, New York NY, Denver CO,
Sponsor: Avistone Biotechnology Co., Ltd.

Sex: All

Age: 18+

Code: NCT06307795

Phase 1, Recruiting

A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction

for
Lung Transplant Rejection
Location: Toronto, Cleveland OH, Ann Arbor MI, Baltimore MD,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT06082037

Phase 3, Recruiting

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

for
Breast Cancer, Metastatic
Location: Toronto, Canton OH, Ann Arbor MI, Fairfax VA,
Sponsor: ALX Oncology Inc.

Sex: All

Age: 18+

Code: NCT07007559

Phase 2, Recruiting

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

for
Geographic Atrophy (GA),
Location: Toronto, Rochester NY, Erie PA, London, Liverpool NY,
Sponsor: ONL Therapeutics

Sex: All

Age: 55+

Code: NCT06659445

Phase 2, Recruiting

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

for
Pruritus
Location: Toronto, London, Boardman OH, Baltimore MD,
Sponsor: Sanofi

Sex: All

Age: 18 - 70+

Code: NCT05263206

Phase 3, Recruiting